References
- Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res [Internet]. 2010 [cited 2019 Sep 25];29:335–375. Available from: https://www.sciencedirect.com/science/article/pii/S135094621000025X
- Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet [Internet]. 2006 [cited 2019 Sep 25];368:1795–1809. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673606697407
- Pagon RA. Retinitis pigmentosa. Surv Ophthalmol [Internet]. 1988 [cited 2019 Sep 25];33:137–177. Available from: https://linkinghub.elsevier.com/retrieve/pii/0039625788900859
- Verbakel SK, Van Huet RAC, Boon CJF, et al. Progress in retinal and eye research non-syndromic retinitis pigmentosa. Prog Retin Eye Res [Internet]. 2018;66:1–30.
- Prokisch H, Hartig M, Hellinger R, et al. A population-based epidemiological and genetic study of X-linked retinitis pigmentosa. Investig Opthalmol Vis Sci [Internet]. 2007 [cited 2019 Sep 25];48:4012. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.07-0071
- Fishman GA. Retinitis pigmentosa. Arch Ophthalmol [Internet]. 1978 [cited 2019 Sep 25];96:822. Available from: http://www.ncbi.nlm.nih.gov/pubmed/655919
- Anasagasti A, Irigoyen C, Barandika O, et al. Current mutation discovery approaches in retinitis pigmentosa. Vision Res [Internet]. 2012 [cited 2019 Sep 25];75:117–129. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0042698912003033
- Csaky KG, Richman EA, Ferris FL. Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium. Investig Ophthalmol Vis Sci. 2008;49:479–489.
- Ferris FL, Kassoff A, Bresnick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol [Internet]. 1982 [cited 2019 Oct 7];94:91–96. Available from: https://www.sciencedirect.com/science/article/pii/0002939482901970?via%3Dihub
- Ferris FL, Sperduto RD. Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol [Internet]. 1982;94:97–98.
- Dong LM, Marsh MJ, Hawkins BS. Measurement and analysis of visual acuity in multicenter randomized clinical trials in the United States: findings from a survey. Ophthalmic Epidemiol [Internet]. 2003 [cited 2019 Oct 7];10:149–165. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12815490
- Sloan L, Rowland WM, Altman A. Comparison of three types of test target for the measurement of visual acuity. Q Rev Ophthalmol. 1952;8:4–16.
- Rosser DA, Cousens SN, Murdoch IE, et al. How sensitive to clinical change are ETDRS logMAR visual acuity measurements? Investig Opthalmol Vis Sci [Internet]. 2003 [cited 2019 Oct 7];44:3278. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12882770
- Kiser AK, Mladenovich D, Eshraghi F, et al. Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease. Optom Vis Sci. 2005;82:946–954.
- Bittner AK, Ibrahim MA, Haythornthwaite JA, et al. Vision test variability in retinitis pigmentosa and psychosocial factors. [ cited 2019 Oct 7]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223543/pdf/nihms315637.pdf
- Tidbury LP, Czanner G, Newsham D. Fiat Lux: the effect of illuminance on acuity testing. Graefe’s Arch Clin Exp Ophthalmol [Internet]. 2016 [cited 2019 Oct 7];254:1091. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884565/#CR2
- Jolly JK, Juenemann K, Boagey H, et al. Validation of electronic visual acuity (EVA) measurement against standardised ETDRS charts in patients with visual field loss from inherited retinal degenerations. Br J Ophthalmol [Internet]. 2019 [cited 2019 Oct 8];1–8. Available from: http://bjo.bmj.com/
- Camparini M, Cassinari P, Ferrigno L, et al. ETDRS-fast: implementing psychophysical adaptive methods to standardized visual acuity measurement with ETDRS charts. Investig Ophthalmol Vis Sci. 2001;42:1226–1231.
- Lin RJ, Ng JS, Nguyen AL. Determinants and standardization of mesopic visual acuity. Optom Vis Sci [Internet]. 2015 [cited 2019 Oct 8];92:559–565. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25906409
- Alexander KR, Derlacki DJ, Fishman GA, et al. Acuity-luminance and foveal increment threshold functions in retinitis pigmentosa. Investig Ophthalmol Vis Sci. 1991;32:1446–1454.
- Sunness JS, Rubin GS, Broman A, et al. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. Ophthalmology [Internet]. 2008 [cited 2019 Oct 8];443:1480–1488. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730515/pdf/nihms125011.pdf
- Lei H, Schuchard RA. Using two preferred retinal loci for different lighting conditions in patients with central scotomas. Invest Ophthalmol Vis Sci [Internet]. 1997 [cited 2019 Oct 8];38:1812–1818. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9286270
- Mollon JD. Color vision: opsins and options. Proc Natl Acad Sci [Internet]. 1999 [cited 2019 Oct 9];96:4743–4745. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.96.9.4743
- Simunovic MP. Acquired color vision deficiency. Surv Ophthalmol [Internet]. 2016;61:132–155.
- Jolly JK, Groppe M, Birks J, et al. Functional defects in color vision in patients with choroideremia. Am J Ophthalmol [Internet]. 2015;160:822–831.e3.
- Talib M, van Schooneveld MJ, van Duuren RJG, et al. Long-term follow-up of retinal degenerations associated with LRAT mutations and their comparability to phenotypes associated with RPE65 mutations. Transl Vis Sci Technol [Internet]. 2019 [cited 2019 Nov 24];8:24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31448181
- Alahmadi BO, Omari AA, Abalem MF, et al. Contrast sensitivity deficits in patients with mutation-proven inherited retinal degenerations 11 medical and health sciences 1109 neurosciences. BMC Ophthalmol. 2018;18:1–6.
- Berson EL, Sandberg MA, Rosner B, et al. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol [Internet]. 1985 [cited 2019 Sep 25];99:240–251. Available from: https://linkinghub.elsevier.com/retrieve/pii/0002939485903514
- Nowomiejska K, Vonthein R, Paetzold J, et al. Comparison between semiautomated kinetic perimetry and conventional goldmann manual kinetic perimetry in advanced visual field loss. Ophthalmology. 2005;112:1343–1354.
- Barnes CS, Schuchard RA, Birch DG, et al. Reliability of semiautomated kinetic perimetry (SKP) and goldmann kinetic perimetry in children and adults with retinal dystrophies. Transl Vis Sci Technol. 2019;8:36.
- Rowe FJ, Rowlands A. Comparison of diagnostic accuracy between octopus 900 and goldmann kinetic visual fields. BioMed Res Int. 2014;2014:1–11.
- Fischer MD, Fleischhauer JC, Gillies MC, et al. A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography. Invest Ophthalmol Vis Sci [Internet]. 2008 [cited 2019 Sep 25];49:3617–3621. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.08-2003
- Ross DF, Fishman GA, Gilbert LD, et al. Variability of visual field measurements in normal subjects and patients with retinitis pigmentosa. Arch Ophthalmol [Internet]. 1984 [cited 2019 Nov 20];102:1004–1010. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6743076
- Bittner AK, Iftikhar MH, Dagnelie G. Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa. Invest Ophthalmol Vis Sci [Internet]. 2011 [cited 2019 Nov 20];52:8042–8046. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21896857
- Cideciyan AV, Charng J, Roman AJ, et al. Progression in X-linked retinitis pigmentosa due to ORF15-RPGR mutations: assessment of localized vision changes over 2 years. Investig Ophthalmol Vis Sci. 2018;59:4558–4566.
- Hood DC, Ramachandran R, Holopigian K, et al. Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosa. Biomed Opt Express [Internet]. 2011 [cited 2019 Oct 22];2:1106–1114. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21559123
- Balasubramanian S, Uji A, Lei J, et al. Interdevice comparison of retinal sensitivity assessments in a healthy population: the CenterVue MAIA and the Nidek MP-3 microperimeters. Br J Ophthalmol. 2017;102:109–113.
- Igarashi N, Matsuura M, Hashimoto Y, et al. Assessing visual fields in patients with retinitis pigmentosa using a novel microperimeter with eye tracking: the MP-3. PLoS One. 2016;11:1–10.
- Cehajic-Kapetanovic J, Xue K, Martinez-fernandez de la Camara C, et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Nat Med. 2020.
- Fishman GA, Birch DG, Holder GEBM. Electrophysiologic testing in disorders of the retina, optic nerve and visual pathway. 2nd ed. USA: Elsevier; 2001.
- Marmor MF, Fulton AB, Holder GE, et al. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol [Internet]. 2009 [cited 2019 Oct 7];118:69–77. Available from: http://link.springer.com/10.1007/s10633-008-9155–4
- Miyake YSK. Clinical electrophysiology. In: Sadda SR, editor. Retina. 5th ed. Elsevier; 2013. p. 202–226.
- Cehajic-Kapetanovic J, Cottriall CL, Jolly JK, et al. Electrophysiological verification of enhanced S-cone syndrome caused by a novel c.755T>C NR2E3 missense variant. Ophthalmic Genet [Internet]. 2019:40:29–33.
- Cao D. Color vision and night vision. In: Ryan SJ, Sadda S, Hinton DR, editors. Retina. 5th ed. USA: Elsevier; 2013. p. 285–299.
- Wu DM, Fawzi AA. Abnormalities of cone and rod function. In: Ryan SJ, Schachat AP, Sadda SR, editors. Retina. 5th ed. USA: Elsevier; 2013. p. 899–906.
- Kemp CM, Jacobson SG, Roman AJ, et al. Abnormal rod dark adaptation in autosomal dominant retinitis pigmentosa with proline-23-histidine rhodopsin mutation. Am J Ophthalmol [Internet]. 1992 cited 2020 Jan 30;113:165–174. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002939414715296
- Chung DC, McCague S, Yu Z-F, et al. Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clin Experiment Ophthalmol [Internet]. 2018 [cited 2020 Feb 6];46:247–259. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28697537
- Klein M, Birch DG. Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST). Doc Ophthalmol [Internet]. 2009 [cited 2020 Feb 6];119:217. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319829/
- Russell S, Bennett J, Wellman JA, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet [Internet]. 2017 [cited 2020 Feb 6];390:849–860. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28712537
- Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 2003 [cited 2019 Oct 9];121:695–706. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archopht.121.5.695
- Lujan BJ, Roorda A, Knighton RW, et al. Revealing Henle’s fiber layer using spectral domain optical coherence tomography. Investig Opthalmol Vis Sci [Internet]. 2011 [cited 2019 Oct 21];52:1486. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21071737
- Staurenghi G, Sadda S, Chakravarthy U, et al. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography. Ophthalmology [Internet]. 2014 [cited 2019 Oct 21];121:1572–1578. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24755005
- Jonnal RS, Kocaoglu OP, Zawadzki RJ, et al. The cellular origins of the outer retinal bands in optical coherence tomography images. Investig Ophthalmol Vis Sci. 2014;55:7904–7918.
- Zhang Y, Cense B, Rha J, et al. High-speed volumetric imaging of cone photoreceptors with adaptive optics spectral-domain optical coherence tomography. Opt Express [Internet]. 2006 [cited 2019 Oct 21];14:4380. Available from: https://www.osapublishing.org/abstract.cfm?URI=oe-14-10–4380
- Jonnal RS, Gorczynska I, Migacz JV, et al. The properties of outer retinal band three investigated with adaptive-optics optical coherence tomography. Investig Ophthalmol Vis Sci. 2017;58:4559–4568.
- Srinivasan VJ, Monson BK, Wojtkowski M, et al. Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci [Internet]. 2008 [cited 2019 Aug 14];49:1571–1579. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18385077
- Hariri AH, Yang Zhang H, Ho A, et al. Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain-optical coherence tomography group information: the principal investigators for the trial of oral valproic acid for retinitis pigmentosa group include Paul HHS public access author manuscript. Retin Found Southwest [Internet]. 2016 [cited 2019 Oct 22];134:628–635. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317200/pdf/nihms850209.pdf
- Takahashi VKL, Takiuti JT, Jauregui R, et al. Structural disease progression in PDE6 -associated autosomal recessive retinitis pigmentosa. Ophthalmic Genet [Internet]. 2018 [cited 2019 Oct 22];39:610–614. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30153077
- Cai CX, Locke KG, Ramachandran R, et al. A comparison of progressive loss of the Ellipsoid Zone (EZ) band in autosomal dominant and X-linked retinitis pigmentosa. Investigative Opthalmology & Visual Science. 2014 [cited 2019 Oct 22];55:7417. Available from: www.iovs.org
- Battaglia Parodi M, La Spina C, Triolo G, et al. Correlation of SD-OCT findings and visual function in patients with retinitis pigmentosa. Graefe’s Arch Clin Exp Ophthalmol [Internet]. 2016 [cited 2019 Oct 22];254:1275–1279. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26472300
- Menghini M, Lujan BJ, Zayit-Soudry S, et al. Correlation of outer nuclear layer thickness with cone density values in patients with retinitis pigmentosa and healthy subjects. Investig Ophthalmol Vis Sci. 2015;56:372–381.
- Sousa K, Fernandes T, Gentil R, et al. Outer retinal layers as predictors of visual acuity in retinitis pigmentosa: a cross-sectional study. Graefe’s Arch Clin Exp Ophthalmol [Internet]. 2019 [cited 2019 Oct 22];257:265–271. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30456418
- Delori FC, Dorey CK, Staurenghi G, et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci [Internet]. 1995 [cited 2019 Oct 23];36:718–729. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7890502
- Schmitz-valckenberg S, Holz FG, Bird AC, et al. Fundus autofluorescence imaging review and perspectives. Retina [Internet]. 2008;28:385–409. Available from: http://journals.lww.com/retinajournal/Abstract/2008/03000/FUNDUS_AUTOFLUORESCENCE_IMAGING__Review_and.2.aspx
- Yung M, Klufas MA, Sarraf D. Clinical applications of fundus autofluorescence in retinal disease. Int J Retin Vitr. 2016;2:1–25.
- Freund KB, Laud K, Lima LH, et al. ACQUIRED VITELLIFORM LESIONS. Retina [Internet]. 2011 [cited 2019 Oct 23];31:13–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21102371
- Wing GL, Blanchard GC, Weiter JJ. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci [Internet]. 1978 [cited 2019 Oct 23];17:601–607. Available from: http://www.ncbi.nlm.nih.gov/pubmed/669891
- Fahim AT, Khan NW, Zahid S, et al. Diagnostic fundus autofluorescence patterns in achromatopsia. Am J Ophthalmol. 2013;156:1211–1219.e2.
- Burke TR, Duncker T, Woods RL, et al. Quantitative fundus autofluorescence in recessive stargardt disease. Investig Opthalmol Vis Sci [Internet]. 2014 [cited 2019 Oct 23];55:2841. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.13-13624
- Robson AG, Michaelides M, Saihan Z, et al. Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update. Doc Ophthalmol [Internet]. 2008 [cited 2019 Oct 23];116:79–89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17985165
- Duncker T, Tabacaru MR, Lee W, et al. Comparison of near-infrared and short-wavelength autofluorescence in retinitis pigmentosa. Invest Ophthalmol Vis Sci [Internet]. 2013 [cited 2019 Oct 23];54:585–591. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23287793
- Lima LH, Burke T, Greenstein VC, et al. Progressive constriction of the hyperautofluorescent ring in retinitis pigmentosa. Am J Ophthalmol [Internet]. 2012 [cited 2019 Oct 23];153:718–727.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22137208
- Cehajic Kapetanovic J, Barnard AR, MacLaren RE. Molecular therapies for choroideremia. Genes (Basel). 2019;10:738.
- Song WK, Nanda A, Cehajic-Kapetanovic J, et al. Enhanced autofluorescence ring findings in RPGR-associated retinitis pigmentosa. 2019.
- Lorenz B, Wabbels B, Wegscheider E, et al. Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology [Internet]. 2004 [cited 2019 Oct 23];111:1585–1594. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15288992
- Lynette F. Lipofuscin and melanin of human retinal pigment epithelium. Investig Ophthalmol Vis Sci. 1978;17:2–3.
- Keilhauer CN, Delori FC. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. Investig Opthalmol Vis Sci [Internet]. 2006 [cited 2019 Oct 23];47:3556. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877429
- Wang Z, Dillon J, Gaillard ER. Antioxidant properties of melanin in retinal pigment epithelial cells. Photochem Photobiol [Internet]. 2006 [cited 2019 Oct 23];82:474. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16613501
- Sundelin SP, Nilsson SE, Brunk UT. Lipofuscin-formation in cultured retinal pigment epithelial cells is related to their melanin content. Free Radic Biol Med [Internet]. 2001 [cited 2019 Oct 23];30:74–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11134897
- Dysli C, Wolf S, Berezin MY, et al. Fluorescence lifetime imaging ophthalmoscopy. Prog Retin Eye Res [Internet]. 2017 [cited 2019 Oct 30];60:120–143. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1350946217300344
- Dysli C, Wolf S, Tran HV, et al. Autofluorescence lifetimes in patients with choroideremia identify photoreceptors in areas with retinal pigment epithelium atrophy. Investig Opthalmol Vis Sci [Internet]. 2016 [cited 2019 Oct 30];57:6714. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.16-20392
- Dysli C, Wolf S, Hatz K, et al. Fluorescence lifetime imaging in stargardt disease: potential marker for disease progression. Investig Opthalmol Vis Sci [Internet]. 2016 [cited 2019 Oct 30];57:832. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.15-18033
- Roorda A, Romero-Borja F, Donnelly Iii W, et al. Adaptive optics scanning laser ophthalmoscopy. Opt Express [Internet]. 2002 [cited 2019 Oct 23];10:405–412. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19436374
- Litts KM, Cooper RF, Duncan JL, et al. Photoreceptor-based biomarkers in AOSLO retinal imaging. Invest Ophthalmol Vis Sci. 2017;58:BIO255–BIO267.
- Roorda A, Zhang Y, Duncan JL, High-resolution in vivo imaging of the RPE mosaic in eyes with retinal disease. Investig Opthalmol Vis Sci [Internet]. 2007 [cited 2019 Oct 23];48: 2297.
- Vohnsen B. Directional sensitivity of the retina: a layered scattering model of outer-segment photoreceptor pigments. Biomed Opt Express [Internet]. 2014 [cited 2019 Oct 23];5:1569–1587. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24877016
- Scoles D, Sulai YN, Langlo CS, et al. In vivo imaging of human cone photoreceptor inner segments. Investig Opthalmol Vis Sci [Internet]. 2014 [cited 2019 Oct 23];55:4244.
- Mullins RF, Kuehn MH, Faidley EA, et al. Differential macular and peripheral expression of bestrophin in human eyes and its implication for Best disease. Investig Ophthalmol Vis Sci. 2007;48:3372–3380.
- Cornelis SS, Bax NM, Zernant J, et al. In silico functional meta-analysis of 5,962 ABCA4 variants in 3,928 retinal dystrophy cases. Hum Mutat. 2017;38:400–408.
- Kjellström U. Association between genotype and phenotype in families with mutations in the ABCA4 gene. Mol Vis [Internet]. 2014 [cited 2019 Oct 30];20:89–104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24453473
- Simonelli F, Testa F, Zernant J, et al. Genotype-phenotype correlation in Italian families with stargardt disease. Ophthalmic Res [Internet]. 2005 [cited 2019 Oct 30];37:159–167. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15942264
- Boon CJF, den Hollander AI, Hoyng CB, et al. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog Retin Eye Res. 2008;27:213–235.
- Becirovic E, Böhm S, Nguyen ONP, et al. In vivo analysis of disease-associated point mutations unveils profound differences in mRNA splicing of peripherin-2 in Rod and cone photoreceptors. Swaroop A, editor. PLOS Genet [Internet]. 2016 [cited 2019 May 31];12:e1005811.
- Cehajic-Kapetanovic J, Birtel J, McClements ME, et al. Clinical and molecular characterization of PROM1-related retinal degeneration. JAMA Network Open. 2019;2:e195752.
- Mizrahi-Meissonnier L, Merin S, Banin E, et al. Variable retinal phenotypes caused by mutations in the X-linked photopigment gene array. Investig Opthalmol Vis Sci [Internet]. 2010 [cited 2019 Oct 30];51:3884. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.09-4592
- Rivolta C, Sweklo EA, Berson EL, et al. Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. Am J Hum Genet [Internet]. 2000 [cited 2019 Oct 30];66:1975–1978. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10775529
- Iannaccone A, Man D, Waseem N, et al. Retinitis pigmentosa associated with rhodopsin mutations: correlation between phenotypic variability and molecular effects. Vision Res. 2006;46:4556–4567.